Lawyers and Settlements
Advertisement
Home Page >> Testosterone Treatment Lawsuit (Androgel, Androderm, Axirom, Bio-T-Gel, Delatestryl, Dep-Testosterone, Fortesta, Striant, Testim & Testopel Lawsuit) >> Articles

Testosterone Treatment Articles

Latest Study Suggests AndroGel Increases Arterial Plaque in Older Men

Latest Study Suggests AndroGel Increases Arterial Plaque in Older Men March 31, 2017. By Gordon Gibb.
Philadelphia, PA: As testosterone side effects lawsuits continue to roll in, a study published last month in JAMA (Journal of the American Medical Association) appears to confirm long-held assertions that testosterone therapy in otherwise healthy men serves only to increase the risks for heart attack and stroke needlessly.
Read [ Latest Study Suggests AndroGel Increases Arterial Plaque in Older Men ]

While FDA Suggests Potential for Testosterone Abuse, Health Canada Takes a Pass

While FDA Suggests Potential for Testosterone Abuse, Health Canada Takes a Pass February 26, 2017. By Gordon Gibb.
Chicago, IL: With the US and Canada remaining both direct neighbors and close trading partners, the Canadian equivalent to the US Food and Drug Administration (FDA) often mirrors safety updates issued by the FDA for drugs and medications. In specific cases, the Canadian position is in some measure more aggressive than its US counterpart. However when the FDA, in October of last year updated warnings to testosterone side effects inherent to testosterone supplements, Health Canada chose not to follow suit.
Read [ While FDA Suggests Potential for Testosterone Abuse, Health Canada Takes a Pass ]

Testosterone Defendant Attempts to Limit Scope of Expert Witness

Testosterone Defendant Attempts to Limit Scope of Expert Witness January 24, 2017. By Gordon Gibb.
Chicago, IL: Plaintiffs in testosterone lawsuits against defendant AbbVie Inc. found themselves momentarily distracted from the allegations at hand earlier this month when the Illinois federal judge overseeing multidistrict litigation over testosterone side effects needed to rule on a motion submitted by the defendant to trim a report from an expert witness in the case.
Read [ Testosterone Defendant Attempts to Limit Scope of Expert Witness ]

FDA Announces New Testosterone Warnings

FDA Announces New Testosterone Warnings November 23, 2016. By Heidi Turner.
Washington, DC: As plaintiffs in testosterone lawsuits wait for the testosterone side effect litigation to move forward, the US Food and Drug Administration (FDA) has announced it has approved new labeling changes that will affect all prescription testosterone therapies. The new testosterone labels affect both the Warning and the Abuse and Dependence sections of the drugs' label.
Read [ FDA Announces New Testosterone Warnings ]

Prescription Testosterone Products Get New FDA Health Warnings

Prescription Testosterone Products Get New FDA Health Warnings October 26, 2016. By Lucy Campbell.
Santa Clara, CA: All prescription testosterone products will now carry class-wide labeling changes introduced by The U.S. Food and Drug Administration (FDA) to warn of the health risks associated with testosterone abuse and dependence.
Read [ Prescription Testosterone Products Get New FDA Health Warnings ]

Belgian AndroGel Manufacturer Attempts to Duck Testosterone Lawsuits

Belgian AndroGel Manufacturer Attempts to Duck Testosterone Lawsuits October 17, 2016. By Gordon Gibb.
Chicago, IL: A manufacturer of a testosterone replacement therapy (TRT) based in Belgium recently petitioned to escape a testosterone lawsuit, given that the pharmaceutical company has little exposure, knowledge or influence over the US market. However, a federal judge in Illinois would have none of it.
Read [ Belgian AndroGel Manufacturer Attempts to Duck Testosterone Lawsuits ]

Testosterone Bellwether Trials Chosen

Testosterone Bellwether Trials Chosen September 1, 2016. By Heidi Turner.
Chicago, IL: For the men who filed testosterone lawsuits alleging they suffered serious side effects as a result of testosterone therapy, news that litigation is moving forward will be welcomed. Eight bellwether cases have been chosen and an initial trial date set for 2017. Claims surrounding testosterone therapy include allegations the therapy is linked to an increased risk of myocardial infarction and venous thromboembolism.
Read [ Testosterone Bellwether Trials Chosen ]

Testosterone’s Benefit is Reversed in Robust Marketing to the Wrong Patient

Testosterone’s Benefit is Reversed in Robust Marketing to the Wrong Patient August 4, 2016. By Gordon Gibb.
Washington, DC: There has never been any debate as to the effectiveness and usefulness of testosterone supplementation for a small cohort of men, for whom supplements can be vitally important. And testosterone therapy isn’t new, having been around for some time (with full blessing from the US Food and Drug Administration) as a treatment for hypogonadism, a condition characterized by severely low levels of testosterone that can lead to severe health problems. For those patients, any risk for testosterone side effects are deemed to be acceptable in view of the benefits for this particular segment of the patient population.
Read [ Testosterone’s Benefit is Reversed in Robust Marketing to the Wrong Patient ]

Study Suggests Testosterone Use Not Backed By Science

Study Suggests Testosterone Use Not Backed By Science July 2, 2016. By Heidi Turner.
Toronto, ON: A new study from Canada suggests the use of testosterone therapy in older men is not based on scientific evidence, leading to more questions about its usefulness. The study, published in June in the Canadian Medical Association Journal, found that it is difficult to base testosterone therapy in older men on levels of testosterone found in younger men. Testosterone lawsuits have been filed against the makers of testosterone therapy, alleging men suffered permanent side effects as a result of the therapy.
Read [ Study Suggests Testosterone Use Not Backed By Science ]

A New Canadian Testosterone Study Is a Catch-22

A New Canadian Testosterone Study Is a Catch-22 June 4, 2016. By Gordon Gibb.
Toronto, ON: While many a testosterone lawsuit claim that testosterone supplements foster testosterone stroke and testosterone heart attack, a recent Canadian study out of the Sunnybrook Health Sciences Center in Toronto suggests that testosterone therapy in older men carries certain benefits, and that the longer a man takes testosterone supplementation, the better off he is.
Read [ A New Canadian Testosterone Study Is a Catch-22 ]

Page: 1  2     Next»

Request Testosterone Treatment Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.

Check Claim Status Advertise with us Legal Funding


Legal Services:

Advertisement
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com